Gencurix Inc. Logo

Gencurix Inc.

Develops molecular diagnostic tests for cancer detection, prognosis, and treatment selection.

229000 | KO

Overview

Corporate Details

ISIN(s):
KR7229000005
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 243 지하이시티 15층, 구로구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Gencurix Inc. is a molecular diagnostics company specializing in the development and commercialization of innovative solutions for oncology. The company leverages core technologies such as liquid biopsy and digital PCR (dPCR) to create precise and reliable tests for cancer detection, prognosis, and treatment selection. Its key products include GenesWell BCT, a multigene test for predicting prognosis in early-stage breast cancer patients, and the GenesWell ddEGFR Mutation Test, a dPCR-based companion diagnostic for targeted anticancer therapies. Gencurix also develops the Droplex platform for early cancer detection by analyzing biomarkers from blood samples. The company aims to advance precision medicine and improve patient outcomes through its portfolio of diagnostic tests and services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 9.7 KB
2025-08-28 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 16.6 KB
2025-08-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-08-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 16.6 KB
2025-08-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 56.4 KB
2025-08-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 53.0 KB
2025-08-11 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-03 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-07-03 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.7 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 34.4 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]증권발행결과(자율공시)
Korean 9.5 KB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]소액공모공시서류(지분증권)
Korean 1.3 MB
2025-06-30 00:00
Share Issue/Capital Change
[기재정정]소액공모실적보고서
Korean 31.1 KB
2025-06-20 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.3 KB
2025-06-20 00:00
Share Issue/Capital Change
소액공모실적보고서
Korean 28.0 KB

Automate Your Workflow. Get a real-time feed of all Gencurix Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gencurix Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gencurix Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia
ALK
Alkermes plc. Logo
Develops medicines for CNS disorders like schizophrenia, bipolar, and sleep disorders.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
Develops personalized cancer drugs using a diagnostic platform to predict patient response.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom
AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Developing off-the-shelf CAR T-cell therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain
ALM
ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG

Talk to a Data Expert

Have a question? We'll get back to you promptly.